ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma

ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma

Abstract Background Cholangiocarcinoma (CHOL) is the second most common primary hepatic malignant tumor, following hepatocellular carcinoma (HCC). CHOL is highly aggressive and heterogeneous resulting in poor prognosis. The diagnosis and prognosis of CHOL has not improved in the past decade. Acyl-Co...

Full description

Bibliographic Details
Main Authors: Shuochen Liu, Shilong Fan, Yirui Wang, Ruixiang Chen, Ziyi Wang, Yaodong Zhang, Wangjie Jiang, Yananlan Chen, Xiao Xu, Yue Yu, Changxian Li, Xiangcheng Li
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Cancer
Subjects:
Cholangiocarcinoma
ACSL4
Prognosis
Immune infiltration
TCGA
GEO
Online Access:https://doi.org/10.1186/s12885-023-10903-5

Internet

https://doi.org/10.1186/s12885-023-10903-5

Similar Items